For the maintenance treatment of vitamin B12 deficiency, the usual dose is 60-100mcg SC/IM, given once per month
Most healthy patients are good candidates for VelaShape treatment, but the following types of people are not suitable for treatment with VelaShape: - Patients with type I or II diabetes - Patients with anticoagulative conditions - Patients prone to blood clots - Photosensitive or sunburnt patients (tanned skin is okay) - Pregnant women (patients should wait until after giving birth to have this treatment) - People with pacemakers, heart valves, metal hip joints or dental plates Is VelaShape safe
Additional mechanistic layering is required before broad conclusions can be drawn
Evaluation of heterotopic bone formation induced by squalane and bone morphogenetic protein composite
Unlike other peptides, which primarily work through appetite suppression and metabolic regulation, these peptides go deeper, supporting mitochondrial function, enhancing fat oxidation, increasing muscle protein synthesis, and even reversing aspects of cellular aging
Early inflammatory response (0-48 hours) benefits from both peptides' effects on cytokine profiles and immune cell function